Annotation Detail for GNL3L
Basic Information Top
| Gene Symbol: | GNL3L ( FLJ10613 ) |
|---|---|
| Gene Full Name: | guanine nucleotide binding protein-like 3 (nucleolar)-like |
| Band: | Xp11.22 |
| Quick Links | Entrez ID:54552; OMIM: NA; Uniprot ID:GNL3L_HUMAN; ENSEMBL ID: ENSG00000130119; HGNC ID: 25553 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Location(AA) | Modification | |
|---|---|---|
| 465 | Phosphoserine. | |
| 502 | N6-acetyllysine. | |
| Location(AA) | Modifications | Resource |
|---|
| Location(AA) | Modification | Resource |
|---|---|---|
| 37 | Phosphothreonine(PKA) | HMM predict |
| 37 | Phosphothreonine(PKC) | HMM predict |
| 84 | Phosphothreonine(PKC) | HMM predict |
| 125 | Phosphotyrosine(EGFR) | HMM predict |
| 196 | Phosphothreonine(PKC) | HMM predict |
| 313 | Phosphoserine(IKK) | HMM predict |
| 333 | Phosphothreonine(CDK) | HMM predict |
| 333 | Phosphothreonine(MAPK) | HMM predict |
| 379 | Phosphotyrosine(INSR) | HMM predict |
| 379 | Phosphotyrosine(Abl) | HMM predict |
| 380 | Phosphoserine(ATM) | HMM predict |
| 476 | N-linked | HMM predict |
| 573 | Phosphoserine(ATM) | HMM predict |
- RefSeq ID: NM_019067
- Location:chrX 54573368-54608697
- strand:+
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| CTCF | G2 | GSE9613 | 54572921 | 54573278 | 357 | 269 |
| P300 | T30-glioblastoma | GSE21026 | 54572635 | 54573858 | 1223 | 122 |
| USF1 | HepG2 | E | 54572058 | 54573215 | 1157 | 732 |
| USF2 | HepG2 | E | 54572642 | 54573143 | 501 | 476 |
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| ER | Fulvestrant-MCF7 | GSE14664 | 54618492 | 54618534 | 42 | 9816 |
| Oct1 | H2O2-Hela | GSE14283 | 54615779 | 54615807 | 28 | 7096 |
| Oct1 | H2O2-Hela | GSE14283 | 54618498 | 54618544 | 46 | 9824 |
| Oct1 | Hela | GSE14283 | 54615045 | 54615079 | 34 | 6365 |
| Oct1 | Hela | GSE14283 | 54617146 | 54617175 | 29 | 8463 |
| RNAII | Tamoxifen-MCF7 | GSE14664 | 54618492 | 54618532 | 40 | 9815 |
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| CTCF | G2 | GSE9613 | 54597148 | 54597560 | 412 | 0 |
| CTCF | G2 | GSE9613 | 54601580 | 54601827 | 247 | 0 |
| H3ac | HepG2 | E | 54573658 | 54575531 | 1873 | 0 |
| Oct1 | Hela | GSE14283 | 54589342 | 54589379 | 37 | 0 |
| PHF8 | 293T | GSE20725 | 54572811 | 54574065 | 1254 | 0 |
| Micro RNA Name | Stem Loop Name | The chromosome that miRNA located | Publication |
|---|---|---|---|
| hsa-let-7b | hsa-let-7b | 22 | 18668040 |
| hsa-let-7b* | hsa-let-7b | 22 | 18668040 |
| hsa-miR-1 | hsa-mir-1-2 | 18 | 18668040 |
| hsa-miR-1 | hsa-mir-1-1 | 20 | 18668040 |
| hsa-miR-155 | hsa-mir-155 | 21 | 18668040 |
| hsa-miR-155* | hsa-mir-155 | 21 | 18668040 |
| hsa-miR-16 | hsa-mir-16-1 | 13 | 18668040 |
| hsa-miR-16 | hsa-mir-16-2 | 3 | 18668040 |
| hsa-miR-30a | hsa-mir-30a | 6 | 18668040 |
| hsa-miR-30a* | hsa-mir-30a | 6 | 18668040 |
| hsa-miR-30b | hsa-mir-30b | 8 | 18668040 |
| hsa-miR-30b* | hsa-mir-30b | 8 | 18668040 |
| hsa-miR-30c | hsa-mir-30c-2 | 6 | 18668040 |
| hsa-miR-30c | hsa-mir-30c-1 | 1 | 18668040 |
| hsa-miR-30c-1* | hsa-mir-30c-1 | 1 | 18668040 |
| hsa-miR-30c-2* | hsa-mir-30c-2 | 6 | 18668040 |
| hsa-miR-30d | hsa-mir-30d | 8 | 18668040 |
| hsa-miR-30d* | hsa-mir-30d | 8 | 18668040 |
| hsa-miR-30e | hsa-mir-30e | 1 | 18668040 |
| hsa-miR-30e* | hsa-mir-30e | 1 | 18668040 |
| ID in Tarbase | Data Type | Support Type | miRNA | Gene | Direct Support | Publication |
|---|---|---|---|---|---|---|
| 1045 | Unknown | pSILAC | miR-16 | GNL3L | down 50-25% | 18668040 |
| Ensembl | Protein Type | Differentially expressed in | Pathology or Event | Mis Regulation | Gene Expression | Tumour Involvement |
| ENSG00000130119 | n_a | n_a | n_a | "muscle cell, lymphocyte" | "benign tumour, malignant tumour, carcinoma, leukaemia, sarcoma" |



Cis-Nats regulation